Does twice-weekly cabergoline improve anthropometrical and biochemical profiles in prediabetes? a randomized double-blind clinical trial pilot study
IJPR-Iranian Journal of Pharmaceutical Research. 2015; 14 (Supp.): 77-86
in English
| IMEMR
| ID: emr-167981
ABSTRACT
Dopaminergic signaling is one of the regulatory pathways being investigated for its implication in glucose metabolism. The aim of this study was to determine the effect of cabergoline on biochemical and anthropometric parameters in prediabetes stage [impaired fasting glucose and impaired glucose tolerance]. In this double blind, placebo-controlled, pilot study, 27 prediabetic adults were randomized to receive 0.25-mg cabergoline twice weekly for two weeks, followed by 0.5 mg twice weekly for next 14 weeks [n = 13] or placebo [n = 14]. All subjects were advised to follow a 500 kcal-deficit energy diet. Fasting plasma glucose [FPG], oral glucose tolerance, glycated hemoglobin [A1c], fasting, and 2-h insulin were measured at baseline and at 16-week follow-up. Homeostasis model assessment [HOMA] 2 was calculated to estimate steady-state beta-cell function, insulin sensitivity, and insulin resistance. Our results showed significant reductions in fasting [P = 0.004] and 2-h plasma glucose [P = 0.01] after treatment, and significant improvements in beta-cell function [P = 0.03] and insulin resistance [P = 0.04] in the cabergoline group. The trend of non-significant A1c changes was decreasing in the cabergoline group versus an increasing trend in the placebo group. All anthropometric parameters were similar between the two groups. Our results revealed that twice-weekly cabergoline could improve glucose metabolism in prediabetes stage. Larger studies of longer duration are warranted to investigate the effect of cabergoline in preventing progression of prediabetes to type 2 diabetes mellitus
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Prediabetic State
/
Biochemistry
/
Blood Glucose
/
Pilot Projects
/
Anthropometry
/
Double-Blind Method
/
Glucose Intolerance
/
Ergolines
Type of study:
Controlled clinical trial
/
Practice guideline
Limits:
Female
/
Humans
/
Male
Language:
English
Journal:
Iran. J. Pharm. Res.
Year:
2015
Similar
MEDLINE
...
LILACS
LIS